TVTX vs. CRDO
TVTX (Travere Therapeutics, Inc.) and CRDO (Credo Technology Group Holding Ltd) are both stocks. TVTX operates in Biotechnology (Healthcare), while CRDO operates in Semiconductors (Technology). Over the past 3 years, TVTX returned 44.35%/yr vs 142.90%/yr for CRDO. At a 0.24 correlation, their price movements are largely independent.
Performance
TVTX vs. CRDO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TVTX achieves a 36.19% return, which is significantly lower than CRDO's 74.31% return.
TVTX
- 1D
- 6.40%
- 1M
- 16.81%
- YTD
- 36.19%
- 6M
- 49.41%
- 1Y
- 248.33%
- 3Y*
- 44.35%
- 5Y*
- 28.09%
- 10Y*
- 12.13%
CRDO
- 1D
- -5.27%
- 1M
- 32.45%
- YTD
- 74.31%
- 6M
- 74.28%
- 1Y
- 237.38%
- 3Y*
- 142.90%
- 5Y*
- —
- 10Y*
- —
TVTX vs. CRDO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | 36.19% | 119.35% | 93.77% | -57.25% | -20.82% |
CRDO Credo Technology Group Holding Ltd | 74.31% | 114.09% | 245.20% | 46.28% | 10.00% |
Correlation
The correlation between TVTX and CRDO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jan 27, 2022 | 0.24 |
Fundamentals
TVTX:
$4.78B
CRDO:
$48.33B
TVTX:
-$0.49
CRDO:
$2.50
TVTX:
9.07
CRDO:
35.55
TVTX:
48.42
CRDO:
23.42
TVTX:
$536.20M
CRDO:
$1.34B
TVTX:
$385.20M
CRDO:
$908.35M
TVTX:
$11.15M
CRDO:
$463.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TVTX vs. CRDO — Risk / Return Rank
TVTX
CRDO
TVTX vs. CRDO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and Credo Technology Group Holding Ltd (CRDO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TVTX | CRDO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.69 | ||
| Sortino ratioReturn per unit of downside risk | +1.29 | ||
| Omega ratioGain probability vs. loss probability | 1.53 | 1.35 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 7.47 | 4.46 | +3.01 |
| Martin ratioReturn relative to average drawdown | 17.27 | 10.76 | +6.51 |
Loading charts...
Drawdowns
TVTX vs. CRDO - Drawdown Comparison
The maximum TVTX drawdown since its inception was -85.43%, which is greater than CRDO's maximum drawdown of -62.04%. Use the drawdown chart below to compare losses from any high point for TVTX and CRDO.
Loading charts...
Drawdown Indicators
| TVTX | CRDO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.43% | -62.04% | -23.39% |
Max Drawdown (1Y)Largest decline over 1 year | -33.49% | -53.59% | +20.10% |
Max Drawdown (3Y)Largest decline over 3 years | -69.77% | -61.05% | -8.72% |
Max Drawdown (5Y)Largest decline over 5 years | -83.12% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.64% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -5.27% | +5.27% |
Average DrawdownAverage peak-to-trough decline | -41.07% | -19.38% | -21.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.46% | 22.17% | -7.71% |
Volatility
TVTX vs. CRDO - Volatility Comparison
The current volatility for Travere Therapeutics, Inc. (TVTX) is 16.06%, while Credo Technology Group Holding Ltd (CRDO) has a volatility of 28.41%. This indicates that TVTX experiences smaller price fluctuations and is considered to be less risky than CRDO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TVTX | CRDO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.06% | 28.41% | -12.35% |
Volatility (6M)Calculated over the trailing 6-month period | 52.58% | 65.16% | -12.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.84% | 85.70% | -13.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.50% | 81.50% | -15.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.38% | 81.50% | -23.12% |
Dividends
TVTX vs. CRDO - Dividend Comparison
Neither TVTX nor CRDO has paid dividends to shareholders.
Financials
TVTX vs. CRDO - Financials Comparison
This section allows you to compare key financial metrics between Travere Therapeutics, Inc. and Credo Technology Group Holding Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TVTX vs. CRDO - Profitability Comparison
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
CRDO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported a gross profit of 298.07M and revenue of 437.00M. Therefore, the gross margin over that period was 68.2%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
CRDO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported an operating income of 155.85M and revenue of 437.00M, resulting in an operating margin of 35.7%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
CRDO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported a net income of 169.10M and revenue of 437.00M, resulting in a net margin of 38.7%.
Frequently Asked Questions
TVTX and CRDO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRDO has higher volatility (28.41%) compared to TVTX (16.06%). In terms of maximum drawdown, TVTX dropped -85.43% vs CRDO's -62.04%.
TVTX currently has the higher Sharpe Ratio (3.48 vs 2.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TVTX and CRDO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer